Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke

MeSH terms

• Adverse Drug Reaction Reporting Systems
• Aging
• Drug Labeling*
• Humans
• Hypogonadism / drug therapy*
• Male
• Myocardial Infarction / chemically induced*
• Risk
• Stroke / chemically induced*
• Testosterone / adverse effects*
• Testosterone / therapeutic use
• United States
• United States Food and Drug Administration